2006 Volume 2006 Issue Supplement117 Pages 16-20
We reviewed 24 cases of maxillary carcinoma who were treated at the Department of Otolaryngology, Hiroshima University Hospital between 1993 and 2002. They were 18 males and 6 females and their ages ranged from 32 to 88 years old. The overall three-year and five-year survival rates were 49.3% and 43.8%, respectively. According to the UICC classification system (1987), one patient was classified in Stage II,5 were in Stage III, and 18 were in Stage IV. The five-year survival rates were 60.0% in Stage III and 42.0% in Stage IV. We assume that relative increase in number of patients in advanced stages may account for reduced survival rates observed in this study as compared with the previous report in 1994.
